Literature DB >> 8866637

Penetration of pefloxacin and its desmethyl metabolite into the uroepithelium after a 800-mg single oral dose in human patients.

J L Moreau1, M J Royer-Morrot, A Lozniewski, G Trackoen, P Delavault, R J Royer.   

Abstract

Penetration of pefloxacin into the uroepithelium was studied in 20 patients (10 men and 10 women) receiving a single oral dose of 800 mg. Samples of serum, urine, and uroepithelium were taken 1.8 h (mean) after the dose. Pefloxacin and its active metabolite, norfloxacin, were assayed by liquid chromatography, and the microbiologically active compounds were quantified by a microbiological assay. Both procedures were correlated (r > 0.7); nevertheless, slight differences detected in concentrations depended on the levels of norfloxacin achieved in the biological samples. The serum and tissue concentrations were higher than the concentration of bactericide (4 micrograms.ml-1), except in one case. The uroepithelium concentration of pefloxacin was proportional to the serum concentration (r = 0.79). The urinary concentrations ranged from 1.2 micrograms.ml-1 to 82.4 micrograms.ml-1. The mean norfloxacin/pefloxacin ratios were 3% in serum, 8% in uroepithelium, and 44% in urine. The mean uroepithelium/serum concentration ratios were 1 for pefloxacin and 2.3 for norfloxacin. This result shows that, at a time close to that of the maximum concentration, there is good penetration of pefloxacin and norfloxacin into the uroepithelium.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8866637     DOI: 10.1007/bf00203786

Source DB:  PubMed          Journal:  Eur J Clin Pharmacol        ISSN: 0031-6970            Impact factor:   2.953


  9 in total

1.  Improved high-performance liquid chromatographic determination of pefloxacin and its metabolite norfloxacin in human plasma and tissue.

Authors:  G Montay; J P Tassel
Journal:  J Chromatogr       Date:  1985-04-12

2.  Dose-dependent pharmacokinetic study of pefloxacin, a new antibacterial agent, in humans.

Authors:  J Barre; G Houin; J P Tillement
Journal:  J Pharm Sci       Date:  1984-10       Impact factor: 3.534

3.  [Acute epididymitis and antibiotherapy. Measurement of the epididymal diffusion of pefloxacin].

Authors:  P Costa; M Galtier; J M Laurelli; G Nivard; J F Louis; M Favier; S Hansel; H Navratil; D Grasset
Journal:  J Urol (Paris)       Date:  1989

4.  A simple isocratic high-pressure liquid chromatographic assay of quinolones in serum.

Authors:  D J Griggs; R Wise
Journal:  J Antimicrob Chemother       Date:  1989-09       Impact factor: 5.790

Review 5.  Pefloxacin. A review of its antibacterial activity, pharmacokinetic properties and therapeutic use.

Authors:  J P Gonzalez; J M Henwood
Journal:  Drugs       Date:  1989-05       Impact factor: 9.546

6.  Pharmacokinetics of pefloxacin in renal insufficiency.

Authors:  G Montay; C Jacquot; J Bariety; R Cunci
Journal:  Eur J Clin Pharmacol       Date:  1985       Impact factor: 2.953

7.  Pharmacokinetics and tissue penetration of orally administered pefloxacin.

Authors:  J M Webberley; J M Andrews; J P Ashby; A McLeod; R Wise
Journal:  Eur J Clin Microbiol       Date:  1987-10       Impact factor: 3.267

8.  Oral pharmacokinetics and ascitic fluid penetration of pefloxacin in cirrhosis.

Authors:  J Cardey; C Silvain; S Bouquet; J P Breux; B Becq-Giraudon; J P Fourtillan; M Beauchant
Journal:  Eur J Clin Pharmacol       Date:  1987       Impact factor: 2.953

9.  Penetration of pefloxacin in human heart valves.

Authors:  N Brion; A Lessana; F Mosset; J J Lefevre; G Montay
Journal:  J Antimicrob Chemother       Date:  1986-04       Impact factor: 5.790

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.